Product Introduction:
Vozuca M 0.3/500 Mg Tablet combines two antidiabetic agents: Voglibose (0.3 mg) and Metformin (500 mg). This combination helps control blood glucose levels in patients with type 2 diabetes, especially when dietary management and exercise alone are not sufficient. Voglibose delays glucose absorption in the intestine, while Metformin improves insulin sensitivity and reduces glucose production in the liver.
Uses:
-
Type 2 Diabetes Mellitus
-
Management of postprandial (after-meal) blood sugar spikes
Benefits:
-
Dual mechanism for better blood glucose control
-
Helps in reducing HbA1c levels
-
Low risk of hypoglycemia when used alone
-
Can delay diabetes-related complications with long-term use
Composition (per tablet):
-
Voglibose – 0.3 mg
-
Metformin Hydrochloride – 500 mg
Side Effects:
-
Flatulence
-
Abdominal discomfort
-
Diarrhea
-
Metallic taste
-
Nausea or vomiting (less common)
-
Rare: Lactic acidosis (a medical emergency – requires immediate attention)
Safety Advice:
-
Take with meals to minimize gastrointestinal side effects
-
Regular monitoring of blood sugar levels is necessary
-
Avoid alcohol consumption while on this medicine
-
Not recommended for use in patients with kidney or liver impairment
-
Consult your doctor before stopping or adjusting the dose
-
Store in a cool, dry place, away from children
